GSK Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Apr 22, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, transaction
Related Tickers: GSK
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on April 22, 2025, that it has purchased a number of its own ordinary shares. The transactions were executed through its corporate stockbroker, Citigroup Global Markets Limited.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of share transactions and does not contain significant new financial or operational information.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker
- April 2025 (date) — Reporting period
- April 22, 2025 (date) — Announcement date
FAQ
What type of transaction is GSK plc reporting?
GSK plc is reporting a transaction in its own shares, specifically the purchase of its ordinary shares.
Who is acting as GSK's stockbroker for these transactions?
Citigroup Global Markets Limited is acting as GSK's corporate stockbroker for these transactions.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is the month of April 2025.
What is the par value of GSK's ordinary shares?
The ordinary shares of GSK plc have a par value of 31¼ pence each.
Is GSK plc filing an annual report on Form 20-F or 40-F?
GSK plc indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 22, 2025 regarding GSK plc (GLAXF).